Detalhe da pesquisa
1.
A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer.
Gynecol Oncol
; 167(1): 96-106, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918200
2.
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
N Engl J Med
; 369(19): 1783-96, 2013 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24180494
3.
Revealing stiffening and brittling of chronic myelogenous leukemia hematopoietic primary cells through their temporal response to shear stress.
Phys Biol
; 13(3): 03LT01, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27254599
4.
Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.
Transpl Infect Dis
; 18(4): 595-600, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27203624
5.
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors.
Am J Hematol
; 88(5): 350-4, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23468307
6.
Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.
Eur J Clin Microbiol Infect Dis
; 31(6): 991-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21909650
7.
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
ESMO Open
; 6(1): 100044, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516148
8.
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease.
Leukemia
; 34(7): 1775-1786, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925317
9.
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.
Leukemia
; 34(4): 966-984, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127639
10.
Chronic disseminated candidiasis and acute leukemia: Impact on survival and hematopoietic stem cell transplantation agenda.
Med Mal Infect
; 48(3): 202-206, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307444
11.
Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.
J Clin Invest
; 107(2): 199-206, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11160136
12.
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP).
Leukemia
; 20(6): 1061-6, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16642048
13.
A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.
Clin Microbiol Infect
; 22(7): 636-41, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27172809
14.
Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activator.
J Am Coll Cardiol
; 17(3): 805-11, 1991 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-1899681
15.
Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact or disrupted endothelium.
J Am Coll Cardiol
; 22(3): 684-9, 1993 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8354799
16.
Limited posterior left atrial cryoablation in patients with chronic atrial fibrillation undergoing valvular heart sugery.
J Am Coll Cardiol
; 36(1): 159-66, 2000 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10898428
17.
Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs.
J Am Coll Cardiol
; 24(3): 795-803, 1994 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8077555
18.
Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator.
J Am Coll Cardiol
; 20(1): 228-35, 1992 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-1607530
19.
Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
J Am Coll Cardiol
; 28(7): 1858-65, 1996 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-8962577
20.
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).
Bone Marrow Transplant
; 35(6): 601-8, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15756285